Mental Health

The US Food and Drug Administration has approved a shortened version of existing brain stimulation protocol for treatment-resistant major depressive disorder.

The FDA has approved the first drug for the treatment of neurotrophic keratitis, a rare disease of the cornea.

The FDA has approved a new drug for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.

The FDA has approved a new drug for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.

The FDA has approved a new drug for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.

The FDA has approved the first generic version of EpiPen and EpiPen Jr auto-injector for the treatment of allergic reactions, including anaphylaxis, in adults and children over 33 pounds.

The FDA has approved the first generic version of EpiPen and EpiPen Jr auto-injector for the treatment of allergic reactions, including anaphylaxis, in adults and children over 33 pounds.

The FDA has approved the first generic version of EpiPen and EpiPen Jr auto-injector for the treatment of allergic reactions, including anaphylaxis, in adults and children over 33 pounds.

The US Food and Drug Administration has granted approval to the first treatment in a new drug class for a nerve condition that affects about 50,000 people worldwide.

The US Food and Drug Administration has granted approval to the first treatment in a new drug class for a nerve condition that affects about 50,000 people worldwide.